On 12th July 1-2pm we’ll be welcoming Dr Sam Bhima from Mid Essex CCG to talk about how to reduce opiate/benzo prescribing in primary care. This is an area that many practitioners find difficult. Sam will give her tips on how to recognise that prescribing is becoming problematic, and how to avoid getting there in the first place.

All NHS registered users can sign up here.

The 'An Introduction to the Quality Premium' slider below has been updated with the Quality Premium Guidance 2017-19 for CCGs and more!

On 25th April we welcomed Denise Downs and Ian Spiers from NHS Digital for part one of two sessions that provide a commissioner level strategic overview of SNOMED CT in general practice.

Med webinar C Click above to view (All NHS).

This bulletin and supporting resources provide practical guidance on deprescribing. Support tools include a medication review template and deprescribing algorithms which are both generic and drug class specific. these tools can be used to guide the process of deprescribing in patients.

Info_bulletin_SQ_preopt.png   Polypharmacy - Practical guide to deprescribing

These guidelines update the previous ONS guidelines and set out the steps for prescribing ONS and provide useful advice on monitoring progress as well as for prescribing in malnutrition associated with special conditions such as palliative care or drug misuse. Advice on self care, reducing inappropriate prescribing and waste is also included. 

Info_bulletin_SQ.png   ONS guidelines

This bulletin discusses the implementation of NICE guidance relevant to medicines optimisation in care homes. A summary of relevant NICE guidance and suggestions to support implementation are offered for each of the relevant NICE guidance. Links to supporting resources are also available. This resource is designed to be shared with care home staff.

Info_bulletin_SQ.png  Care homes - Implementation of NICE guidelines

Bulletin 165 - Glycopyrronium (SPOT-List) is now available to all PrescQIPP users.

This bulletin is the latest SPOT(Specials Prescribing Optimisation Tool) support bulletin and focuses on the use of glycopyrronium in hypersalivation (both off label and unlicenced special usage). It also covers use in other conditions in both adults and children. 

Info_bulletin_SQ_preopt.png   Glycopyrronium (SPOT-List)

Bulletin 162 - Polypharmacy - Agreeing treatment goals and discontinuation criteria is now available to all PrescQIPP users.

This bulletin, briefing and supporting resources support prescribers in being able to agree the goals of a treatment and discuss the discontinuation criteria with patients before they initiate a treatment. Tools are available to support the discussion with patients as well as identify the factors that should be considered before prescribing.

Info_bulletin_SQ.png   Polypharmacy - Agreeing treatment goals and discontinuation criteria

Bulletin 158 - Prescribing in ADHD is now available to all PrescQIPP users.

These resources support the appropriate prescribing and review of ADHD treatments including initiation and monitoring of treatment. An audit is available to support identification of patients needing a review.

Info_bulletin_SQ.png   Prescribing in ADHD